Breast Cancer — Market Sizing Across Nine Countries
HEALTHCARE BUSINESS INSIGHTS
CENTRAL & EASTERN EUROPE · BREAST CANCER
How can a company quantify patient populations and treatment opportunities across different breast cancer markets?
The business challenge. How can a company quantify patient populations and treatment opportunities across different breast cancer markets?
Our approach. FMR conducted two waves of quantitative oncologist research with patient record collection and desk research. The work examined HR+/HER2- and triple-negative breast cancer, disease stages, treatment lines, mutations and patient characteristics.
How insights were applied. Country-level patient and treatment evidence enabled comparison of market opportunities and informed geographic prioritisation and commercial planning. These are research implications; subsequent commercial outcomes have not been independently verified.